Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis

NCT ID: NCT05546788

Last Updated: 2023-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-20

Study Completion Date

2023-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Periodontitis is a serious gum infection that damages the soft tissue and, without treatment, can destroy the bone that supports your teeth.

Hydroxylated poly methoxy flavones are a combination of naturally occurring flavonoids extracted from the orange peel and exert anti-inflammatory, antibacterial, and antifungal activity however, this extract is poorly soluble and poorly absorbable. In this work, this extract was formulated as a solid dispersion formulation to enhance its biological activity and then incorporated into a gel base and used in the treatment of periodontitis after clinical debridement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the study, there are 3 groups; the first one first one received plain sodium carboxymethylcellulose. Group II received chlorhexidine gel. GroupIII received Hydroxylated poly methoxy flavones solid dispersion incorporated into sodium carboxymethylcellulose gel.

In all groups, there is clinical debridement before injection of gels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Disease Periodontal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Three groups of patients with periodontitis, Group I received plain gel Group II received chlorhexidine gel Group III received hydroxylated polymethoxy flavones solid dispersion gel
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hydroxylated polymethyl flavones group

SRP then hydroxylated polymethyl flavones addition

Group Type ACTIVE_COMPARATOR

scaling and root planing

Intervention Type PROCEDURE

subgingival Depridement

hydroxylated poly methoxy flavones

Intervention Type DRUG

Received hydroxylated poly methoxy flavones extract solid dispersion incorporated into sodium carboxymethylcellulose gel

Chlorohexidine group

SRP then Chlorohexidine gel application

Group Type ACTIVE_COMPARATOR

scaling and root planing

Intervention Type PROCEDURE

subgingival Depridement

chlorhexidine

Intervention Type DRUG

Received chlorhexidine gel

placebo group

SRP then placebo gel application

Group Type PLACEBO_COMPARATOR

scaling and root planing

Intervention Type PROCEDURE

subgingival Depridement

placebo

Intervention Type DRUG

Received placebo gel

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

scaling and root planing

subgingival Depridement

Intervention Type PROCEDURE

hydroxylated poly methoxy flavones

Received hydroxylated poly methoxy flavones extract solid dispersion incorporated into sodium carboxymethylcellulose gel

Intervention Type DRUG

chlorhexidine

Received chlorhexidine gel

Intervention Type DRUG

placebo

Received placebo gel

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with periodontitis stage I-II
* free from any systemic disorders.
* no mobility - non-smokers - no parafunctional habits.
* Each patient with minimum three periodontitis sites ( split-mouth study)

Exclusion Criteria

* Smokers.
* patients with diabetes, and hypertension.
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Mortada

Head of Department of Oral Medicine, Periodontology and Diagnosis

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.S.V.U 122/22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.